Janus Henderson Investors US’s Alder Biopharmaceuticals ALDR Stock Holding History

Janus Henderson Investors US’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$107M	Buy	5,167,085 +230,044	+5%	+$5.09M	0.09%	277
2016 Q4	$103M	Buy	4,937,041 +368,158	+8%	+$9.57M	0.09%	287
2016 Q3	$150M	Sell	4,568,883 -573,127	-11%	-$17.5M	0.13%	220
2016 Q2	$128M	Sell	5,142,010 -96,140	-2%	-$2.6M	0.11%	248
2016 Q1	$128M	Buy	5,238,150 +356,955	+7%	+$8.26M	0.11%	240
2015 Q4	$161M	Buy	4,881,195 +641,340	+15%	+$21.7M	0.14%	199
2015 Q3	$139M	Buy	4,239,855 +3,376,540	+391%	+$144M	0.12%	214
2015 Q2	$45.7M	Buy	+863,315	New	+$31.4M	0.04%	459

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Janus Henderson Investors US's ALDR Position: Q1 2017 in Review

Janus Henderson Investors US increased its Alder Biopharmaceuticals (ALDR) stake by 4.7% in Q1 2017, buying an estimated $5.09M and bringing the position to 5,167,085 shares worth $107M. The position accounts for 0.09% of the portfolio, ranked #277.

Janus Henderson Investors US first reported a position in ALDR in Q2 2015 and has held it in 8 quarters since. The position peaked at $161M in Q4 2015. 142 funds tracked by Wall St. Rank hold ALDR as of Q1 2017.

Janus Henderson Investors US held 5,167,085 shares of Alder Biopharmaceuticals worth $107M as of Q1 2017.
Janus Henderson Investors US bought 230,044 Alder Biopharmaceuticals shares in Q1 2017, an estimated $5.09M.
Alder Biopharmaceuticals made up 0.09% of Janus Henderson Investors US's portfolio in Q1 2017, its #277 holding.
Janus Henderson Investors US first reported a position in Alder Biopharmaceuticals in Q2 2015 and has held it in 8 quarters since.
Janus Henderson Investors US's Alder Biopharmaceuticals position peaked at $161M in Q4 2015.
142 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.